These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34782317)

  • 1. Identifying multimorbidity clusters with the highest primary care use: 15 years of evidence from a multi-ethnic metropolitan population.
    Soley-Bori M; Bisquera A; Ashworth M; Wang Y; Durbaba S; Dodhia H; Fox-Rushby J
    Br J Gen Pract; 2022 Mar; 72(716):e190-e198. PubMed ID: 34782317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic differences in early onset multimorbidity and associations with health service use, long-term prescribing, years of life lost, and mortality: A cross-sectional study using clustering in the UK Clinical Practice Research Datalink.
    Eto F; Samuel M; Henkin R; Mahesh M; Ahmad T; Angdembe A; Hamish McAllister-Williams R; Missier P; J Reynolds N; R Barnes M; Hull S; Finer S; Mathur R
    PLoS Med; 2023 Oct; 20(10):e1004300. PubMed ID: 37889900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnic inequalities in the impact of COVID-19 on primary care consultations: a time series analysis of 460,084 individuals with multimorbidity in South London.
    McGreevy A; Soley-Bori M; Ashworth M; Wang Y; Rezel-Potts E; Durbaba S; Dodhia H; Fox-Rushby J
    BMC Med; 2023 Jan; 21(1):26. PubMed ID: 36658550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic differences in physical and mental multimorbidity in working age adults with a history of depression and/or anxiety.
    Ronaldson A; de la Torre JA; Broadbent M; Ashworth M; Armstrong D; Bakolis I; Hatch SL; Hotopf M; Dregan A
    Psychol Med; 2023 Oct; 53(13):6212-6222. PubMed ID: 36420618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying longitudinal clusters of multimorbidity in an urban setting: A population-based cross-sectional study.
    Bisquera A; Gulliford M; Dodhia H; Ledwaba-Chapman L; Durbaba S; Soley-Bori M; Fox-Rushby J; Ashworth M; Wang Y
    Lancet Reg Health Eur; 2021 Apr; 3():100047. PubMed ID: 34557797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease patterns in high-cost individuals with multimorbidity: a retrospective cross-sectional study in primary care.
    Soley-Bori M; Ashworth M; McGreevy A; Wang Y; Durbaba S; Dodhia H; Fox-Rushby J
    Br J Gen Pract; 2024 Mar; 74(740):e141-e148. PubMed ID: 38325891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethnic inequities in multimorbidity among people with psychosis: a retrospective cohort study.
    Fonseca de Freitas D; Pritchard M; Shetty H; Khondoker M; Nazroo J; Hayes RD; Bhui K
    Epidemiol Psychiatr Sci; 2022 Jul; 31():e52. PubMed ID: 35844106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Multimorbidity and Polypharmacy Patterns in the Elderly: A Cross-Sectional Study in Primary Health Care.
    Stafford G; Villén N; Roso-Llorach A; Troncoso-Mariño A; Monteagudo M; Violán C
    Int J Environ Res Public Health; 2021 Sep; 18(17):. PubMed ID: 34501805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics, service use and mortality of clusters of multimorbid patients in England: a population-based study.
    Zhu Y; Edwards D; Mant J; Payne RA; Kiddle S
    BMC Med; 2020 Apr; 18(1):78. PubMed ID: 32272927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethnic inequalities in mental and physical multimorbidity in women of reproductive age: a data linkage cohort study.
    Catalao R; Dorrington S; Pritchard M; Jewell A; Broadbent M; Ashworth M; Hatch S; Howard L
    BMJ Open; 2022 Jul; 12(7):e059257. PubMed ID: 35840295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do multi-morbidity and polypharmacy affect general practice attendance and referral rates? A retrospective analysis of consultations.
    O'Regan A; O'Doherty J; O'Connor R; Cullen W; Niranjan V; Glynn L; Hannigan A
    PLoS One; 2022; 17(2):e0263258. PubMed ID: 35113926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimorbidity patterns, polypharmacy and their association with liver and kidney abnormalities in people over 65 years of age: a longitudinal study.
    Villén N; Guisado-Clavero M; Fernández-Bertolín S; Troncoso-Mariño A; Foguet-Boreu Q; Amado E; Pons-Vigués M; Roso-Llorach A; Violán C
    BMC Geriatr; 2020 Jun; 20(1):206. PubMed ID: 32532213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of multimorbidity and pharmacotherapy: a total population cross-sectional study.
    Forslund T; Carlsson AC; Ljunggren G; Ärnlöv J; Wachtler C
    Fam Pract; 2021 Mar; 38(2):132-140. PubMed ID: 32766818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Journey to multimorbidity: longitudinal analysis exploring cardiovascular risk factors and sociodemographic determinants in an urban setting.
    Ashworth M; Durbaba S; Whitney D; Crompton J; Wright M; Dodhia H
    BMJ Open; 2019 Dec; 9(12):e031649. PubMed ID: 31874873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimorbidity clusters among long-term breast cancer survivors in Spain: Results of the SURBCAN study.
    Jansana A; Poblador-Plou B; Gimeno-Miguel A; Lanzuela M; Prados-Torres A; Domingo L; Comas M; Sanz-Cuesta T; Del Cura-Gonzalez I; Ibañez B; Abizanda M; Duarte-Salles T; Padilla-Ruiz M; Redondo M; Castells X; Sala M;
    Int J Cancer; 2021 Nov; 149(10):1755-1767. PubMed ID: 34255861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inequalities in developing multimorbidity over time: A population-based cohort study from an urban, multi-ethnic borough in the United Kingdom.
    Bisquera A; Turner EB; Ledwaba-Chapman L; Dunbar-Rees R; Hafezparast N; Gulliford M; Durbaba S; Soley-Bori M; Fox-Rushby J; Dodhia H; Ashworth M; Wang Y
    Lancet Reg Health Eur; 2022 Jan; 12():100247. PubMed ID: 34901910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary care consultation length by deprivation and multimorbidity in England: an observational study using electronic patient records.
    Gopfert A; Deeny SR; Fisher R; Stafford M
    Br J Gen Pract; 2021; 71(704):e185-e192. PubMed ID: 33318089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project).
    Prados-Torres A; Del Cura-González I; Prados-Torres D; López-Rodríguez JA; Leiva-Fernández F; Calderón-Larrañaga A; López-Verde F; Gimeno-Feliu LA; Escortell-Mayor E; Pico-Soler V; Sanz-Cuesta T; Bujalance-Zafra MJ; Morey-Montalvo M; Boxó-Cifuentes JR; Poblador-Plou B; Fernández-Arquero JM; González-Rubio F; Ramiro-González MD; Coscollar-Santaliestra C; Martín-Fernández J; Barnestein-Fonseca MP; Valderas-Martínez JM; Marengoni A; Muth C;
    Implement Sci; 2017 Apr; 12(1):54. PubMed ID: 28449721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of timeframes to define long term conditions and sociodemographic factors on prevalence of multimorbidity using disease code frequency in primary care electronic health records: retrospective study.
    Beaney T; Clarke J; Woodcock T; Majeed A; Barahona M; Aylin P
    BMJ Med; 2024; 3(1):e000474. PubMed ID: 38361663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot.
    McCarthy C; Clyne B; Corrigan D; Boland F; Wallace E; Moriarty F; Fahey T; Hughes C; Gillespie P; Smith SM
    Implement Sci; 2017 Aug; 12(1):99. PubMed ID: 28764753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.